Miki N. Hew - Concepedia

Author

Miki N. Hew

Amsterdam UMC Location University of Amsterdam

Also Known As

M. Hew, M.N. Hew, Miki Hew, Miki N. Hew

Publications

401

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam The Netherlands Cancer Institute Amsterdam UMC Location Vrije Universiteit Amsterdam Medicines Evaluation Board

About

Miki N. Hew is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, tumor microenvironment, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	107
2	Pathology	2	2	58
3	Public Health	1	1	49
4	Emergency Medicine	1	1	49
5	Immunology	1	1	26

Miki N. Hew

Publications

384

Citations

H-Index

Page 1

	Year	Citations
Critical Appraisal of the PADUA Classification and Assessment of the R.E.N.A.L. Nephrometry Score in Patients Undergoing Partial Nephrectomy Miki N. Hew, Barbaros Başeskioğlu, Kurdo Barwari, The Journal of Urology	2011	151
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials Rik J. Verheijden, Jolien S. de Groot, Babs O. Fabriek, Journal of Clinical Oncology	2024	72
ECG Monitoring of Treatment Response in Pulmonary Arterial Hypertension Patients Ivo R. Henkens, C. Tji Gan, S. A. van Wolferen, CHEST Journal HypertensionEcg MonitoringElectrophysiological EvaluationPulmonary Arterial HypertensionCardiovascular Disease	2008	49
Age and Gender Related Differences in Renal Cell Carcinoma in a European Cohort Miki N. Hew, Rens Zonneveld, Intan P.E.D. Kümmerlin, The Journal of Urology	2012	42
Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study Alexandre Ingels, Miki N. Hew, Ferrán Algaba, World Journal of Urology UrologyGenitourinary CancerKidney ResearchVimentin Over-expressionMedicine	2016	32
High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors across different solid tumors B. Gülave, Miki N. Hew, Jolien S. de Groot, ESMO Open Lymphoid NeoplasiaCancer ImmunosurveillanceAutoimmune DiseaseMedicineImmunology	2021	26
The 1‐year decline in estimated glomerular filtration rate ( <scp>eGFR</scp> ) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same Miki N. Hew, Dedan Opondo, Ernesto Cordeiro, British Journal of Urology	2013	12

Page 1